Ngā hua rapu - Kim Hunter‐Schaedle
- E whakaatu ana i te 1 - 4 hua o te 4
-
1
Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria mā Scott R. Plotkin, Jaishri O. Blakeley, D. Gareth Evans, C. Oliver Hanemann, Theo J.M. Hulsebos, Kim Hunter‐Schaedle, Ganjam V. Kalpana, Bruce R. Korf, Ludwine Messiaen, Laura Papi, Nancy Ratner, Larry S. Sherman, Miriam J. Smith, Anat Stemmer‐Rachamimov, Jérémie Vitte, Marco Giovannini
I whakaputaina 2013Artigo -
2
Skeletal abnormalities in neurofibromatosis type 1: Approaches to therapeutic options mā Florent Elefteriou, Mateusz Kolanczyk, Aaron Schindeler, David Viskochil, Janet M. Hock, Elizabeth K. Schorry, Alvin H. Crawford, Jan M. Friedman, David G. Little, Juha Peltonen, John C. Carey, David S. Feldman, Xijie Yu, Linlea Armstrong, Patricia Birch, David L. Kendler, Stefan Mundlos, Feng‐Chun Yang, Gina Agiostratidou, Kim Hunter‐Schaedle, David A. Stevenson
I whakaputaina 2009Revisão -
3
Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2 mā Jaishri O. Blakeley, D. Gareth Evans, John R. Adler, Derald E. Brackmann, Ruihong Chen, Rosalie E. Ferner, C. Oliver Hanemann, Gordon J. Harris, Susan Huson, Abraham Jacob, Michel Kalamarides, Matthias A. Karajannis, Bruce R. Korf, Victor‐Felix Mautner, Andrea I. McClatchey, Harry Miao, Scott R. Plotkin, William H. Slattery, Anat Stemmer‐Rachamimov, D. Bradley Welling, Patrick Y. Wen, Brigitte C. Widemann, Kim Hunter‐Schaedle, Marco Giovannini
I whakaputaina 2011Artigo -
4
Consensus Recommendations to Accelerate Clinical Trials for Neurofibromatosis Type 2 mā D. Gareth Evans, Michel Kalamarides, Kim Hunter‐Schaedle, Jaishri O. Blakeley, Jeffrey C. Allen, Dusica Babovic-Vuskanovic, Allan J. Belzberg, Gideon Bollag, Ruihong Chen, Emmanuelle DiTomaso, John G. Golfinos, Gordon J. Harris, Abraham Jacob, Ganjam V. Kalpana, Matthias A. Karajannis, Bruce R. Korf, Razelle Kurzrock, Meng Law, Andrea I. McClatchey, Roger J. Packer, Pamela C. Roehm, Allan E. Rubenstein, William H. Slattery, James H. Tonsgard, D. Bradley Welling, Brigitte C. Widemann, Kaleb Yohay, Marco Giovannini
I whakaputaina 2009Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Neurofibromatosis
Neurofibromatosis type 2
Pathology
Clinical trial
Intensive care medicine
Biology
Internal medicine
Bioinformatics
Cancer
Carcinogenesis
Chromatin remodeling
Disease
Gene
Genetics
Germline
Germline mutation
Histone
Medical genetics
Mutation
Natural history
Neurofibromatoses
Neurofibromin 1
Oncology
SMARCB1